HOME >> MEDICINE >> NEWS
7,000 Pharmaceutical scientists to share latest drug developments and discoveries

AAPS Annual Meeting Takes Place in New Orleans, November 14-18

ALEXANDRIA, Va.-- More than 7,000 pharmaceutical scientists will gather in New Orleans, November 14-18 at the 1999 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, The Quest for the Magic Bullet: An Outstanding Century. Scientists from around the world will share the latest developments in the field of pharmaceutical research and development.

"The AAPS Annual Meeting is the largest gathering of pharmaceutical scientists worldwide," said AAPS President Larry Augsburger, Ph.D. "Scientists at this meeting will present more than 2,500 contributed papers featuring important scientific findings."

The plenary session, "The Quest for the Magic Bullet: An Outstanding Century," takes place on Nov. 15, 8:30 a.m. - 12:00 p.m. The session will reflect on outstanding achievements in the pharmaceutical sciences during the 20th Century and examine how recent advances in research, development and technology will lead the pharmaceutical sciences into the next century.

"The plenary session promises to provide a glimpse into the future of drug therapy and health care and a recap of the most significant advances made in the pharmaceutical sciences over the past century," said AAPS Annual Meeting Program Chair Jay Sisco, Ph.D.

The meeting will offer nine short courses, 17 roundtables and 43 symposium sessions, which focus on topics such as the future of genetic immunization, recent developments in drug delivery and targeting, advances in vaccines, emerging analytical/bioanalytical techniques, particle engineering and modeling techniques, and competition in a patient-driven market.

Meeting highlights include:

  • 61623: Jane E. Henney, M.D., Commissioner of the Food and Drug Administration, will deliver the keynote address at the meeting's opening session on Nov. 14. Dr. Henney will outline her vision for the FDA as the agency ente
    '"/>


Contact: Amy Miller
miller@aaps.org
703--518-8417
American Association of Pharmaceutical Scientists
14-Jun-1999


Page: 1 2

Related medicine news :

1. Pharmaceutical marketing tactics hold little sway with prescribing physicians
2. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
3. Pharmaceutical Achievers
4. Pharmaceutical industry still failing health needs of less-developed countries
5. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
6. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
7. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
8. American Association of Pharmaceutical Scientists Dietary Supplements Forum examines science behind nutraceuticals
9. Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years
10. Pharmaceuticals and personal care products
11. New publisher announced for Journal Of Pharmaceutical Sciences

Post Your Comments:
(Date:5/22/2013)... study suggests that disturbed sleep in adolescents is ... uncertainly about future success. However, perceived support ... have a protective effect. , Results show ... mood and greater uncertainty about future success. Higher ... teachers were associated with significantly fewer sleep disruptions ...
(Date:5/22/2013)... the parents are married are less likely to be ... the University of Houston. , "Childhood obesity is a ... one-third of all U.S. children ages 2-17 overweight or ... sociology at Rice and director of Rice,s Kinder Institute ... been conducted to explore the impact of family structure ...
(Date:5/22/2013)... May 22, 2013 Slip and fall ... by a number of factors. A December 2010 CDC ... following hazards as the most common: contaminants on the ... weather conditions, inadequate lighting, and lack of handrails (i). ... bruises, strained ligaments and muscles, fractures, broken bones, ...
(Date:5/22/2013)... Monroe, OH (PRWEB) May 22, 2013 ... indoor air quality merchandise ranging from furnace filters, ... DiscountFurnaceFilters.com is excited to add Stadler Form's ... a fashionable summer product line (fans, aroma diffusers ... , Stadler Form’s Otto Fan is the perfect ...
(Date:5/22/2013)... Peak Solar introduces unique, interactive solar training seminars, ... customers make informed buying choices. Research studies tell companies ... is to give them the tools needed to make ... heart. Solar training seminars will be introduced onto the ... solar kits . , Poised to help both residential ...
Breaking Medicine News(10 mins):Health News:Parent and teacher support protects teens from sleep problems and depression 2Health News:Children of married parents less likely to be obese 2Health News:Children of married parents less likely to be obese 3Health News:Law Firm Releases Slip and Fall Accident Informational Graphic to Show the Frequency and Cost of These Incidents 2Health News:Law Firm Releases Slip and Fall Accident Informational Graphic to Show the Frequency and Cost of These Incidents 3Health News:DiscountFurnaceFilter.com Now Offers Stadler Form Products - Providing Solutions to All Your Summer Needs 2Health News:Online Solar Training Seminars Aimed at Informing Consumers 2
(Date:5/22/2013)... 22, 2013 Hemoglobin A1C levels increased ... Type 2 diabetes, while modest improvements in A1C ... and can lead to substantial healthcare cost savings, ... Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th ... sponsored by Valeritas, makers of the V-Go ® ...
(Date:5/22/2013)... -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced ... at the following conferences. , Deutsche Bank 38th ... 29, 2013 , Presentation time: 12:00 p.m. P.T. ... Presentation date: Wednesday June 5, 2013 , Presentation time: ... live webcast and 30-day archive of these presentations will be ...
(Date:5/22/2013)... , May 22, 2013  Grifols, a global ... , presented results from a study demonstrating that a ... Inhibitor [Human]) increased levels of the alpha 1 ... to levels that are considered within the normal range ... condition in which low levels of the alpha 1 ...
Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4
Cached News: